Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Provivi

Explore full profile

A groundbreaking science-based company creating scalable, safer insect control technology that will improve the quality of life for all humans and our world

Santa Monica, United StatesFounded 2013Food
Valuation $100–250M Last recorded · 2021
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Provivi and the history behind them.

About Provivi

Provivi operates in the agricultural chemicals sector, providing farmers with alternatives to traditional insecticides. The company was founded in 2013 by Dr. Pedro Coelho, Dr. Peter Meinhold, and 2018 Nobel laureate in Chemistry, Dr. Frances Arnold. Dr. Arnold, a professor at Caltech, pioneered methods of directed evolution to create new proteins. Dr. Coelho holds a Ph.D. in Chemistry from Caltech and a Master's from the University of Oxford, with a career focused on developing pheromone-based pest control solutions.

The core of Provivi's business is the development and production of insect pheromones for mating disruption. This preventative method uses dispensers that release species-specific pheromones into a field, which confuses male insects and disrupts their ability to find mates, thereby reducing the pest population in the next generation. This approach avoids harming non-target organisms, including beneficial insects and pollinators. The company's technology, based on biocatalysis and fermentation, is designed to significantly lower the manufacturing cost of pheromones, making them economically viable for large-scale row crops like corn, rice, and soy.

Provivi's product line, under names like Pheron®, includes solutions targeting major agricultural pests such as the Fall Armyworm and the Yellow Stem Borer. Products like "Provivi FAW™" and "Pherogen® Granulo FAW" have received regulatory approval in markets including Mexico and Brazil. The company offers its products in various formulations, such as dispensers for smaller farms and liquid sprays for application with existing farm equipment on larger operations. Its business model involves both direct-to-farmer sales and strategic partnerships with major agricultural companies like Syngenta and Godrej Agrovet for distribution and commercialization in global markets, including Indonesia, India, and Mexico.

Since its inception, Provivi has raised over $230 million in funding across multiple rounds. Key investors include the Gates Foundation, BASF Venture Capital, Kairos Ventures, and Temasek. This capital has supported product development, regulatory approvals, and commercial launches. For instance, a 2022 pilot program in Guanajuato, Mexico, demonstrated the effectiveness of its mating disruption technique on corn crops. After its first commercial year in Mexico, the company reported serving over 1,000 growers across 100,000 hectares.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2013
Headquarters
Santa Monica, United States
Employees
84
Open positions
None listed
Dealroom signal
64.5/100
Industry
Food
Sub-industry
AgriTech
Sector
Food, Biotechnology, Pest Control, Biopesticides, Chemical, Synthetic Biology, Spinout, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
CONVERTIBLEOther financing Oct 2021 $0 — Undisclosed —
SERIES COther financing Feb 2021 $10M $228M Bill & Melinda Gates Foundation —
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

Provivi website traffic

Latest recorded traffic for Provivi is 2.3K monthly website visits, up 15% over the last three months. Provivi's team declined 1.2% over the past year.

Latest monthly visits2.3K 3-month web change+15% 1-year team growth-1.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • US National Science Foundation

Series A4 investors entered at this stage

  • Kairos Ventures
  • Spruce Capital Partners
  • DuPont
  • Kairos

Series B and later5 investors entered at this stage

Other known investors2 additional known investors

  • Caltech, California Institute of Technology
  • Massachusetts Institute of Technology
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
7 countries with
team presence
🇺🇸 United States53.1%
🇲🇽 Mexico18.4%
🇮🇩 Indonesia12.2%
🇧🇷 Brazil10.2%
🇹🇭 Thailand2%
Top 5 of 7 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Provivi on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Provivi’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.